HEADER MEMBRANE PROTEIN 12-JUN-19 6RZ4 TITLE CRYSTAL STRUCTURE OF CYSTEINYL LEUKOTRIENE RECEPTOR 1 IN COMPLEX WITH TITLE 2 PRANLUKAST COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYSTEINYL LEUKOTRIENE RECEPTOR 1,SOLUBLE CYTOCHROME B562, COMPND 3 CYSTEINYL LEUKOTRIENE RECEPTOR 1; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: CYSLTR1,CYSTEINYL LEUKOTRIENE D4 RECEPTOR,LTD4 RECEPTOR,G- COMPND 6 PROTEIN COUPLED RECEPTOR HG55,HMTMF81,CYTOCHROME B-562,CYSLTR1, COMPND 7 CYSTEINYL LEUKOTRIENE D4 RECEPTOR,LTD4 RECEPTOR,G-PROTEIN COUPLED COMPND 8 RECEPTOR HG55,HMTMF81; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ESCHERICHIA COLI; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606, 562; SOURCE 5 GENE: CYSLTR1, CYSLT1, CYBC; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9 KEYWDS GPCR, LCP, MEMBRANE PROTEIN, CYSTEINYL LEUKOTRIENE, LTD4, CYSLT1, KEYWDS 2 CYSLTR1, CYSLT1R ASTHMA, PRANLUKAST, BRIL, SODIUM SITE, CYSTEINYL KEYWDS 3 LEUKOTRIENE RECEPTOR 1 EXPDTA X-RAY DIFFRACTION AUTHOR A.LUGININA,A.GUSACH,E.MARIN,A.MISHIN,R.BROUILLETTE,P.POPOV, AUTHOR 2 A.SHIRYAEVA,E.BESSERER-OFFROY,J.M.LONGPRE,E.LYAPINA,A.ISHCHENKO, AUTHOR 3 N.PATEL,V.POLOVINKIN,N.SAFRONOVA,A.BOGORODSKIY,E.EDELWEISS,W.LIU, AUTHOR 4 A.BATYUK,V.GORDELIY,G.W.HAN,P.SARRET,V.KATRITCH,V.BORSHCHEVSKIY, AUTHOR 5 V.CHEREZOV REVDAT 5 24-JAN-24 6RZ4 1 REMARK REVDAT 4 30-MAR-22 6RZ4 1 REMARK REVDAT 3 08-APR-20 6RZ4 1 REMARK DBREF HELIX SSBOND REVDAT 3 2 1 LINK ATOM REVDAT 2 15-JAN-20 6RZ4 1 SOURCE REMARK DBREF SEQADV REVDAT 2 2 1 HELIX ATOM REVDAT 1 30-OCT-19 6RZ4 0 JRNL AUTH A.LUGININA,A.GUSACH,E.MARIN,A.MISHIN,R.BROUILLETTE,P.POPOV, JRNL AUTH 2 A.SHIRIAEVA,E.BESSERER-OFFROY,J.M.LONGPRE,E.LYAPINA, JRNL AUTH 3 A.ISHCHENKO,N.PATEL,V.POLOVINKIN,N.SAFRONOVA,A.BOGORODSKIY, JRNL AUTH 4 E.EDELWEISS,H.HU,U.WEIERSTALL,W.LIU,A.BATYUK,V.GORDELIY, JRNL AUTH 5 G.W.HAN,P.SARRET,V.KATRITCH,V.BORSHCHEVSKIY,V.CHEREZOV JRNL TITL STRUCTURE-BASED MECHANISM OF CYSTEINYL LEUKOTRIENE RECEPTOR JRNL TITL 2 INHIBITION BY ANTIASTHMATIC DRUGS. JRNL REF SCI ADV V. 5 X2518 2019 JRNL REFN ESSN 2375-2548 JRNL PMID 31633023 JRNL DOI 10.1126/SCIADV.AAX2518 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.30 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 12755 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 641 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.96 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.97 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3020 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2514 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2868 REMARK 3 BIN R VALUE (WORKING SET) : 0.2513 REMARK 3 BIN FREE R VALUE : 0.2532 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.03 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 152 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2999 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 170 REMARK 3 SOLVENT ATOMS : 16 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.62 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 65.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.69490 REMARK 3 B22 (A**2) : -6.45430 REMARK 3 B33 (A**2) : 3.75940 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 15.81840 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.490 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 2.308 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.333 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.878 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.832 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3258 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4401 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1088 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 567 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3258 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 435 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3773 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.89 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 1.69 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.07 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6RZ4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-JUN-19. REMARK 100 THE DEPOSITION ID IS D_1200011357. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-DEC-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID30B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97624 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS 20161101 REMARK 200 DATA SCALING SOFTWARE : XSCALE 20161101 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12749 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.700 REMARK 200 R MERGE (I) : 0.26900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 8.00 REMARK 200 R MERGE FOR SHELL (I) : 0.87100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 1.12-2829 REMARK 200 STARTING MODEL: 4XNW,4EIY REMARK 200 REMARK 200 REMARK: CRYSTALS HAD A TWIGGY SHAPE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM SODIUM CITRATE PH 6 200-600 MM REMARK 280 LITHIUM NITRATE 30-38% V/V PEG400, PH 6.0, LIPIDIC CUBIC PHASE, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 22.67500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 500 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -2 REMARK 465 GLY A -1 REMARK 465 THR A 0 REMARK 465 MET A 1 REMARK 465 ASP A 2 REMARK 465 GLU A 3 REMARK 465 THR A 4 REMARK 465 GLY A 5 REMARK 465 ASN A 6 REMARK 465 LEU A 7 REMARK 465 THR A 8 REMARK 465 VAL A 9 REMARK 465 SER A 10 REMARK 465 SER A 1107 REMARK 465 GLY A 1108 REMARK 465 LYS A 223 REMARK 465 ASN A 224 REMARK 465 ASN A 301 REMARK 465 PHE A 302 REMARK 465 ARG A 303 REMARK 465 LYS A 304 REMARK 465 ARG A 305 REMARK 465 LEU A 306 REMARK 465 SER A 307 REMARK 465 THR A 308 REMARK 465 PHE A 309 REMARK 465 ARG A 310 REMARK 465 LYS A 311 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 11 OG REMARK 470 THR A 13 OG1 CG2 REMARK 470 ASP A 16 CG OD1 OD2 REMARK 470 ASP A 20 CG OD1 OD2 REMARK 470 GLN A 24 CG CD OE1 NE2 REMARK 470 LYS A 50 CE NZ REMARK 470 TYR A 52 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 HIS A 53 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 54 CG CD CE NZ REMARK 470 GLN A 59 CG CD OE1 NE2 REMARK 470 LYS A 86 CG CD CE NZ REMARK 470 LEU A 90 CG CD1 CD2 REMARK 470 ARG A 121 NE CZ NH1 NH2 REMARK 470 GLN A 130 CG CD OE1 NE2 REMARK 470 ILE A 132 CG1 CG2 CD1 REMARK 470 VAL A 135 CG1 CG2 REMARK 470 LYS A 138 CG CD CE NZ REMARK 470 LYS A 139 CD CE NZ REMARK 470 LYS A 168 CG CD CE NZ REMARK 470 LYS A 172 CE NZ REMARK 470 LYS A 183 CE NZ REMARK 470 VAL A 188 CG1 CG2 REMARK 470 LYS A 218 CD CE NZ REMARK 470 LYS A 222 CD CE NZ REMARK 470 SER A1000 OG REMARK 470 GLU A1004 CD OE1 OE2 REMARK 470 GLU A1008 CG CD OE1 OE2 REMARK 470 ASP A1012 CG OD1 OD2 REMARK 470 LYS A1015 CG CD CE NZ REMARK 470 LYS A1019 CG CD CE NZ REMARK 470 LYS A1027 CG CD CE NZ REMARK 470 LYS A1047 CG CD CE NZ REMARK 470 LYS A1059 CE NZ REMARK 470 LYS A1077 CG CD CE NZ REMARK 470 VAL A1084 CG1 CG2 REMARK 470 LYS A1085 CD CE NZ REMARK 470 GLN A1093 OE1 NE2 REMARK 470 LYS A1095 CG CD CE NZ REMARK 470 ILE A1102 CG1 CG2 CD1 REMARK 470 LEU A1106 CG CD1 CD2 REMARK 470 GLU A 263 CG CD OE1 OE2 REMARK 470 THR A 264 OG1 CG2 REMARK 470 LYS A 265 CG CD CE NZ REMARK 470 GLN A 274 CG CD OE1 NE2 REMARK 470 PHE A 296 CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 85 41.73 -83.90 REMARK 500 GLN A 178 -72.56 -71.54 REMARK 500 PHE A 198 -65.73 -144.93 REMARK 500 TYR A1101 -38.96 -133.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 OLC A 2003 REMARK 610 OLC A 2004 REMARK 610 OLC A 2006 REMARK 610 OLC A 2007 REMARK 610 OLC A 2008 REMARK 610 OLC A 2009 REMARK 610 OLC A 2010 REMARK 610 OLC A 2011 REMARK 610 OLA A 2012 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A2002 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 69 OD1 REMARK 620 2 SER A 110 OG 101.9 REMARK 620 3 ASN A 287 O 101.9 142.8 REMARK 620 4 ASN A 287 OD1 92.7 70.6 80.1 REMARK 620 5 ASP A 291 OD2 93.2 130.3 76.1 156.2 REMARK 620 N 1 2 3 4 DBREF 6RZ4 A 1 222 UNP Q9Y271 CLTR1_HUMAN 1 222 DBREF 6RZ4 A 1001 1105 UNP P0ABE7 C562_ECOLX 23 127 DBREF 6RZ4 A 335 311 UNP Q9Y271 CLTR1_HUMAN 223 311 SEQADV 6RZ4 GLY A -2 UNP Q9Y271 EXPRESSION TAG SEQADV 6RZ4 GLY A -1 UNP Q9Y271 EXPRESSION TAG SEQADV 6RZ4 THR A 0 UNP Q9Y271 EXPRESSION TAG SEQADV 6RZ4 SER A 1000 UNP Q9Y271 LINKER SEQADV 6RZ4 TRP A 1007 UNP P0ABE7 MET 29 CONFLICT SEQADV 6RZ4 ILE A 1102 UNP P0ABE7 HIS 124 CONFLICT SEQADV 6RZ4 LEU A 1106 UNP P0ABE7 LINKER SEQADV 6RZ4 SER A 333 UNP P0ABE7 LINKER SEQADV 6RZ4 GLY A 334 UNP P0ABE7 LINKER SEQRES 1 A 423 GLY GLY THR MET ASP GLU THR GLY ASN LEU THR VAL SER SEQRES 2 A 423 SER ALA THR CYS HIS ASP THR ILE ASP ASP PHE ARG ASN SEQRES 3 A 423 GLN VAL TYR SER THR LEU TYR SER MET ILE SER VAL VAL SEQRES 4 A 423 GLY PHE PHE GLY ASN GLY PHE VAL LEU TYR VAL LEU ILE SEQRES 5 A 423 LYS THR TYR HIS LYS LYS SER ALA PHE GLN VAL TYR MET SEQRES 6 A 423 ILE ASN LEU ALA VAL ALA ASP LEU LEU CYS VAL CYS THR SEQRES 7 A 423 LEU PRO LEU ARG VAL VAL TYR TYR VAL HIS LYS GLY ILE SEQRES 8 A 423 TRP LEU PHE GLY ASP PHE LEU CYS ARG LEU SER THR TYR SEQRES 9 A 423 ALA LEU TYR VAL ASN LEU TYR CYS SER ILE PHE PHE MET SEQRES 10 A 423 THR ALA MET SER PHE PHE ARG CYS ILE ALA ILE VAL PHE SEQRES 11 A 423 PRO VAL GLN ASN ILE ASN LEU VAL THR GLN LYS LYS ALA SEQRES 12 A 423 ARG PHE VAL CYS VAL GLY ILE TRP ILE PHE VAL ILE LEU SEQRES 13 A 423 THR SER SER PRO PHE LEU MET ALA LYS PRO GLN LYS ASP SEQRES 14 A 423 GLU LYS ASN ASN THR LYS CYS PHE GLU PRO PRO GLN ASP SEQRES 15 A 423 ASN GLN THR LYS ASN HIS VAL LEU VAL LEU HIS TYR VAL SEQRES 16 A 423 SER LEU PHE VAL GLY PHE ILE ILE PRO PHE VAL ILE ILE SEQRES 17 A 423 ILE VAL CYS TYR THR MET ILE ILE LEU THR LEU LEU LYS SEQRES 18 A 423 LYS SER MET LYS SER ALA ASP LEU GLU ASP ASN TRP GLU SEQRES 19 A 423 THR LEU ASN ASP ASN LEU LYS VAL ILE GLU LYS ALA ASP SEQRES 20 A 423 ASN ALA ALA GLN VAL LYS ASP ALA LEU THR LYS MET ARG SEQRES 21 A 423 ALA ALA ALA LEU ASP ALA GLN LYS ALA THR PRO PRO LYS SEQRES 22 A 423 LEU GLU ASP LYS SER PRO ASP SER PRO GLU MET LYS ASP SEQRES 23 A 423 PHE ARG HIS GLY PHE ASP ILE LEU VAL GLY GLN ILE ASP SEQRES 24 A 423 ASP ALA LEU LYS LEU ALA ASN GLU GLY LYS VAL LYS GLU SEQRES 25 A 423 ALA GLN ALA ALA ALA GLU GLN LEU LYS THR THR ARG ASN SEQRES 26 A 423 ALA TYR ILE GLN LYS TYR LEU SER GLY LYS ASN LEU SER SEQRES 27 A 423 SER HIS LYS LYS ALA ILE GLY MET ILE MET VAL VAL THR SEQRES 28 A 423 ALA ALA PHE LEU VAL SER PHE MET PRO TYR HIS ILE GLN SEQRES 29 A 423 ARG THR ILE HIS LEU HIS PHE LEU HIS ASN GLU THR LYS SEQRES 30 A 423 PRO CYS ASP SER VAL LEU ARG MET GLN LYS SER VAL VAL SEQRES 31 A 423 ILE THR LEU SER LEU ALA ALA SER ASN CYS CYS PHE ASP SEQRES 32 A 423 PRO LEU LEU TYR PHE PHE SER GLY GLY ASN PHE ARG LYS SEQRES 33 A 423 ARG LEU SER THR PHE ARG LYS HET KNT A2001 36 HET NA A2002 1 HET OLC A2003 13 HET OLC A2004 12 HET OLC A2005 25 HET OLC A2006 7 HET OLC A2007 21 HET OLC A2008 17 HET OLC A2009 6 HET OLC A2010 10 HET OLC A2011 11 HET OLA A2012 11 HETNAM KNT PRANLUKAST HETNAM NA SODIUM ION HETNAM OLC (2R)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETNAM OLA OLEIC ACID HETSYN OLC 1-OLEOYL-R-GLYCEROL FORMUL 2 KNT C27 H23 N5 O4 FORMUL 3 NA NA 1+ FORMUL 4 OLC 9(C21 H40 O4) FORMUL 13 OLA C18 H34 O2 FORMUL 14 HOH *16(H2 O) HELIX 1 AA1 SER A 11 THR A 51 1 41 HELIX 2 AA2 SER A 56 CYS A 74 1 19 HELIX 3 AA3 THR A 75 HIS A 85 1 11 HELIX 4 AA4 GLY A 92 PHE A 127 1 36 HELIX 5 AA5 ILE A 132 SER A 155 1 24 HELIX 6 AA6 SER A 156 LEU A 159 5 4 HELIX 7 AA7 ASP A 179 VAL A 196 1 18 HELIX 8 AA8 PHE A 198 ALA A 1020 1 46 HELIX 9 AA9 ASN A 1022 ALA A 1043 1 22 HELIX 10 AB1 PRO A 1045 GLU A 1049 5 5 HELIX 11 AB2 SER A 1055 ASN A 1080 1 26 HELIX 12 AB3 LYS A 1083 ILE A 1102 1 20 HELIX 13 AB4 SER A 226 SER A 245 1 20 HELIX 14 AB5 SER A 245 HIS A 261 1 17 HELIX 15 AB6 PRO A 266 SER A 286 1 21 HELIX 16 AB7 ASN A 287 CYS A 289 5 3 HELIX 17 AB8 PHE A 290 SER A 298 1 9 SHEET 1 AA1 2 GLN A 164 LYS A 165 0 SHEET 2 AA1 2 THR A 171 LYS A 172 -1 O LYS A 172 N GLN A 164 SSBOND 1 CYS A 14 CYS A 267 1555 1555 2.03 SSBOND 2 CYS A 96 CYS A 173 1555 1555 2.03 LINK OD1 ASP A 69 NA NA A2002 1555 1555 2.65 LINK OG SER A 110 NA NA A2002 1555 1555 2.45 LINK O ASN A 287 NA NA A2002 1555 1555 3.08 LINK OD1 ASN A 287 NA NA A2002 1555 1555 2.25 LINK OD2 ASP A 291 NA NA A2002 1555 1555 2.32 CRYST1 58.630 45.350 86.430 90.00 91.47 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017056 0.000000 0.000438 0.00000 SCALE2 0.000000 0.022051 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011574 0.00000